Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
Alexandre Faisal-Cury,Renata Bertazzi Levy,Maria Fernanda Tourinho,Alexandre Grangeiro,José Eluf-Neto +4 more
TL;DR: A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women, highlighting the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents.
read more
Abstract: Since March 2014, the quadrivalent HPV vaccine has been incorporated into the Brazilian Unified Health Care System and began to be offered, without direct costs, for girls from 9 to 13 years of age. Older female adolescents would have the option to be vaccinated at private health care system being responsible for the payment of HPV vaccine. The present study aimed to evaluate the coverage rates and predictors of HPV vaccination in Brazil among two groups of female adolescents: eligible and non-eligible for the HPV vaccination public program. We used data from the 2015 Brazilian National Adolescent School-Based Health Survey, which involved a probabilistic sample of 5404 female adolescents students at public and private schools. Using a questionnaire, we gathered information on sociodemographic characteristics, sexual behavior, and respondent perception of parental supervision and have been vaccinated for HPV. Age-specific vaccination rates were analyzed in girls aged 9 to 13 at the time of public vaccination (eligible for public policy), as well among those 14 to 17 years old not eligible by the Ministry of Health for vaccination. We used Poisson regression models to investigate associated factors. HPV vaccine coverage was 83.5 and 21.8% among eligible and non-eligible populations, respectively. In both populations, the chance of being vaccinated decreased with older age. In the eligible population there is a greater chance of being vaccinated among ethnic group “pardas” but not with other indicators of socioeconomic status. In the non-eligible population, there was a clear association between higher vaccine coverage and greater maternal education and living with the mother. Our findings highlight the importance of public policies to minimize inequities in access to cancer prevention measures in vulnerable adolescents. A public policy of HPV vaccination for older female adolescents would increase coverage with possible reduction of HPV-related diseases in this group of women.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis.
Thinley Dorji,Tanawin Nopsopon,Saran Tenzin Tamang,Krit Pongpirul,Krit Pongpirul,Krit Pongpirul +5 more
TL;DR: In this article, a meta-analysis was performed to assess the uptake of HPV vaccination in LMICs at the beginning of the global strategy to eliminate cervical cancer and describes the gaps and challenges.
Follow-up of women screened for cervical cancer in São Paulo, Brazil: An analysis of the times to diagnostic investigation and treatment.
Caroline Madalena Ribeiro,Isabel dos Santos Silva,José Eluf Neto,Lise Cristina Pereira Baltar Cury,Gulnar Azevedo e Silva +4 more
TL;DR: In this article, a record-linkage cohort study was conducted in Brazil to assess the quality of the follow-up care of women with abnormal screening tests that require further investigation, and the median time to diagnosis was 190 days with the probability of undergoing a diagnostic investigation within 30 days of the abnormal screening test being 7%.
8
How attitudes towards vaccination change in the face of an outbreak.
Ewa Talarek,Magdalena Chazan,Paulina Winiarska,Łukasz Dembiński,Tomasz Sobierajski,Aleksandra Banaszkiewicz +5 more
TL;DR: During an outbreak, people would be more likely to accept vaccination at locations other than a health-care facility, both normally and during an outbreak.
7
User Engagement on a Novel Educational Health Intervention Aimed at Increasing HPV Vaccine Uptake in Hong Kong: a Qualitative Study
Janita Pak Chun Chau,Suzanne Hoi Shan Lo,Laveeza Butt,Vivian W Y Lee,Grace Lui,Alexander Y.L. Lau +5 more
TL;DR: A multi-disciplinary school-based HPV health-promotion program (MDL-SHPVP) aimed at raising HPV knowledge levels and increasing vaccine uptake has therefore been developed to address vaccine hesitancy as mentioned in this paper .
References
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay,Isabelle Soerjomataram,Rajesh Dikshit,Sultan Eser,Colin Mathers,Marise Souto Rebelo,Donald Maxwell Parkin,David Forman,Freddie Bray +8 more
TL;DR: The GLOBOCAN series of the International Agency for Research on Cancer (IARC) as mentioned in this paper provides estimates of the worldwide incidence and mortality from 27 major cancers and for all cancers combined for 2012.
Multiple Imputation by Chained Equations (MICE): Implementation in Stata
Patrick Royston,Ian R. White +1 more
TL;DR: Ice is described, an implementation in Stata of the MICE approach to multiple imputation, and real data from an observational study in ovarian cancer is used to illustrate the most important of the many options available with ice.
1.2K
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
Laia Bruni,Mireia Diaz,Leslie Barrionuevo-Rosas,Rolando Herrero,Freddie Bray,F. Xavier Bosch,Silvia de Sanjosé,Xavier Castellsagué +7 more
TL;DR: Worldwide cumulative coverage of publicly funded HPV immunisation programmes up to 2014 is quantified, and the potential impact on future cervical cancer cases and deaths is estimated.
774
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2019.
Laurie D. Elam-Evans,David Yankey,James A. Singleton,Natalie Sterrett,Lauri E. Markowitz,Charnetta Williams,Benjamin Fredua,Lucy A McNamara,Shannon Stokley +8 more
TL;DR: Three vaccines are recommended by the Advisory Committee on Immunization Practices (ACIP) for routine vaccination of adolescents aged 11-12 years to protect against 1) pertussis; 2) meningococcal disease caused by types A, C, W, and Y; and 3) human papillomavirus-associated cancers.
National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018.
Tanja Y. Walker,Laurie D. Elam-Evans,David Yankey,Lauri E. Markowitz,Charnetta Williams,Benjamin Fredua,James A. Singleton,Shannon Stokley +7 more
TL;DR: verage with ≥1 dose of HPV vaccine was higher among adolescents whose parents reported receiving a provider recommendation; however, prevalence of parents reporting receiving a recommendation for adolescent HPV vaccination varied by state (range = 60%-91%).